FDA ANDA · ANDA213191

MESALAMINE

Sponsor: TEVA PHARMS INC

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
ANDA213191
TYPE
ANDA
ORIGINAL APPROVAL
2024-08-22
LATEST ACTION
2026-10-15
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

MESALAMINEPrescription
MESALAMINE 800MG · TABLET, DELAYED RELEASE · ORAL

Approval history

2026-10-15Labeling · Supplement 2 · standardAP
2024-08-22UNKNOWN · Original · standardAP